Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy
- 30 September 1994
- journal article
- Published by Elsevier in Kidney International
- Vol. 46 (3) , 797-806
- https://doi.org/10.1038/ki.1994.335
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic ratsKidney International, 1992
- Heparin stimulates proteoglycan synthesis by vascular smooth muscle cells while supressing cellular proliferationAtherosclerosis, 1992
- Early increased renal procollagen α1(IV) mRNA levels in streptozotocin induced diabetesKidney International, 1992
- Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation.Journal of Clinical Investigation, 1991
- N-desulfated/acetylated heparin ameliorates the progression of renal disease in rats with subtotal renal ablation.Journal of Clinical Investigation, 1988
- Role for angiotensin II in an overt functional proteinuriaKidney International, 1986
- Role of heparin as a protective agent following reduction of renal massKidney International, 1984
- Heparan Sulfate–Rich Anionic Sites in the Human Glomerular Basement MembraneNew England Journal of Medicine, 1983
- In vivo studies on basement membrane synthesis in diabetic and nondiabetic ratsZeitschrift für Die Gesamte Experimentelle Medizin, 1982
- Synthetic Polysaccharides. III. Polyglucose Sulfates1Journal of the American Chemical Society, 1958